Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine
The objective of the present randomized, open-label, naturalistic 8-week study was to compare the efficacy and safety of treatment with clonazepam (N = 63) and paroxetine (N = 57) in patients with panic disorder with or without agoraphobia. Efficacy assessment included number of panic attacks and cl...
Main Authors: | A.E. Nardi, A.M. Valença, R.C. Freire, M.D. Mochcovitch, R. Amrein, A. Sardinha, M.N. Levitan, I. Nascimento, V.L. de-Melo-Neto, A.L. King, A.C. de O. e Silva, A.B. Veras, G.P. Dias, G.L. Soares-Filho, R.T. da Costa, M.A. Mezzasalma, M.R. de Carvalho, A.C. de Cerqueira, J.E. Hallak, J.A. Crippa, M. Versiani |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2011-04-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000400015 |
Similar Items
-
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine
by: A.E. Nardi, et al.
Published: (2011-04-01) -
Development and validation of an HPTLC method for the simultaneous estimation of Clonazepam and Paroxetine hydrochloride using a DOE approach
by: Purvi Shah, et al.
Published: (2017-01-01) -
Hyperekplexia; Response to Clonazepam
by: J Gordon Millichap
Published: (1992-08-01) -
Effects of personality on the association between paroxetine plasma concentration and response
by: Tomita T, et al.
Published: (2018-11-01) -
Clonazepam, um campeão de vendas no Brasil. Por quê?
by: Cruz, Nelma Lourenco de Matos [UNIFESP]
Published: (2018)